Market Introduction
Transcranial magnetic stimulator (TMS), also referred to as repetitive transcranial magnetic stimulator (rTMS), is a type of brain stimulation in which a changing magnetic field is applied to a specific area of the brain. An electromagnetic coil is placed against patient’s scalp near forehead during the rTMS session. It is a noninvasive procedure used for diagnostic and therapeutic applications. The US Transcranial Magnetic Stimulator (TMS) market is segmented on the basis of type, age group, application, and country.
Market Overview and Dynamics
The Transcranial magnetic stimulator (TMS) market was valued at US$ 309.53 million in 2020 and is projected to reach US$ 631.29 million by 2028; it is expected to grow at a CAGR of 9.4% from 2021 to 2028.
The major factors such as the growing prevalence of neurological disorders, increasing geriatric population and neurological disorders associated with age, and presence of well-established healthcare facilities drive the growth of the US Transcranial Magnetic Stimulator (TMS) market. However, the high cost of diagnostic and treatment restricts the market growth.
Key Market Segments
By type, the US Transcranial Magnetic Stimulator (TMS) market is bifurcated into single or paired pulse TMS and repetitive TMS (rTMS). In 2020, the single or paired pulse TMS segment held a larger share of the market, However, the market for the repetitive TMS (rTMS) segment is expected to grow at a faster rate during the coming years.
Major Sources and Companies Listed
A few of the major primary and secondary sources referred to while preparing the report on the US Transcranial Magnetic Stimulator (TMS) market are Centers for Disease Control and Prevention, Ministry of Health, Foreign Direct Investment, Organization for Economic Co-operation and Development, and Food and Drug Administration.
Reasons to Buy report
- To understand the US transcranial magnetic stimulator (TMS) market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the market
- Efficiently plan M&A and partnership deals in the market by identifying market segments with the most promising probable sales
- Make knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the US transcranial magnetic stimulator (TMS) market
- Obtain market revenue forecast for market by various segments from 2020 to 2028 in the US.
US Transcranial Magnetic Stimulator (TMS) Market –
By Type
- Single or Paired Pulse TMS
- Repetitive TMS (rTMS)
By Age Group
- Adults
-
Children
By Application
- Research
- Diagnostic
- Therapeutic
Company Profiles
- BrainsWay Ltd
- Nexstim
- Magstim
- Neuronetics
- TMS Neuro Solutions
- MagVenture, Inc.
- eNeura Inc.
- Neurosoft
- MAG & More Gmb
US Transcranial Magnetic Stimulator (TMS) Market Strategic Insights
US Transcranial Magnetic Stimulator (TMS)Market Report Highlights
| Report Attribute | Details |
| Market size in 2020 | US$ 309.53 Million |
| Market Size by 2028 | US$ 631.29 Million |
| CAGR (2021 - 2028) | 9.4% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| United States | |
| Market leaders and key company profiles |
|
US Transcranial Magnetic Stimulator (TMS) Market Country and Regional Insights
